New statement of OECD GLP compliance

mar 22, 2021

Happy and proud to share that Lablytica has just received their new statement of OECD GLP compliance for Analytical and Clinical Chemistry testing (8) from SWEDACs inspection on the 10 November 2020.

Statement-of-GLP-compliance-Lablytica-Life-Science_10November-2020Ladda ner

You might also like

CTR acquires preclinical toxicology company

CTR acquires preclinical toxicology company

apr 6, 2021

Center for Translational Research Sweden AB (CTR) acquires Toxicology Knowledge Team Sweden AB (TKT) further strengthening the CTR group with optimised toxicological support. From April 1, TKT is a fully owned subsidiary to the holding company CTR. The activities at...

CTR acquires preclinical toxicology company

apr 6, 2021

Center for Translational Research Sweden AB (CTR) acquires Toxicology Knowledge Team Sweden AB (TKT) further strengthening the CTR group with optimised toxicological support. From April 1, TKT is a fully owned subsidiary to the holding company CTR. The activities at...

David Pekar becomes CEO at Lablytica

nov 1, 2020

Lablytica Life Science AB started in November 2019 when Recipharm’s GLP bioanalysis business was divested to Center for Translational Research AB (CTR). David Pekar has since then been the Site Manager and Chief Scientific Officer at Lablytica. As announced by CTR,...